UNSPSC 51282933: Olamufloxacin

This classification denotes a quinolone antibiotic with the molecular formula C20H23FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LJG8KL1435, chemically known as 3-quinolinecarboxylic acid, 5-amino-7-(7-amino-5-azaspiro(2,4)hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxo-, (s)- but generally known as olamufloxacin, which bears US NIH Compound Identifier 477670. European Medicines Agency schedules Olamufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03495MIG.

UNSPSC 51282933 Olamufloxacin, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two opportunities identified in the recent record are pharmaceutical procurements, but neither involves olamufloxacin directly. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both antibiotics in the fluoroquinolone or tetracycline families, not olamufloxacin. Seminole County, Florida issued an IFB for naloxone and safe drug deactivation systems, which falls outside pharmaceutical antibiotic procurement entirely. State and local health departments and counties do procure pharmaceuticals through cooperative purchasing vehicles and piggyback contracts, typically at the department or county health level, but the code shows no recent open solicitations or awarded contracts specifically naming olamufloxacin.

The mismatch between the code's nominal scope and recent opportunities tagged under it suggests either miscoding in the state and local procurement system or that olamufloxacin procurement does not regularly surface in public notice records at the state and local level. Activity is scattered across Florida and Illinois, with no evident concentration or pattern of repeat buyers seeking this specific product. No recent open solicitations for olamufloxacin were identified; the Illinois award is closed and the Seminole County opportunity covers unrelated products. Firms pursuing this code should verify whether state and local health departments and institutional buyers actually source olamufloxacin through public procurement channels or whether the product is typically acquired through other supply mechanisms or federal-level contracts.